Citi Maintains Buy Rating and Raises Price Target for Thermo Fisher Scientific

10/24/2026
Impact: 50
Healthcare

Citi analyst Patrick B. Donnelly has maintained a 'Buy' rating for Thermo Fisher Scientific (TMO) and increased the price target from $685 to $800, indicating a positive outlook on the company's performance and market position. This adjustment is part of ongoing analyst coverage, highlighting continued interest from financial institutions in Thermo Fisher.

AI summary, not financial advice

Share: